{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:49Z","timestamp":1789506709504,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128872","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:38:30Z","timestamp":1782131910000},"page":"128872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Purified gamma-irradiated influenza A vaccine demonstrates high immunogenicity and protection against a drifted H1N1 strain"],"prefix":"10.1016","volume":"88","author":[{"given":"Mariana","family":"Couto Moniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Krokhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Bryan","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Comerford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alsharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128872_bb0005","author":"WHO"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128872_bb0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.vaccine.2020.12.018","article-title":"Global production capacity of seasonal and pandemic influenza vaccines in 2019","volume":"39","author":"Sparrow","year":"2021","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128872_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/v13060977","article-title":"Molecular characterization of seasonal Influenza A and B from hospitalized patients in Thailand in 2018\u20132019","volume":"13","author":"Boonnak","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128872_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761632","article-title":"Enhanced immunogenicity of a whole-inactivated Influenza A virus vaccine using optimised irradiation conditions","volume":"12","author":"Singleton","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128872_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128872_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128872_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126381","article-title":"Real-world effectiveness of influenza vaccine over a decade during the 2011\u20132021 seasons\u2014implications of vaccine mismatch","volume":"42","author":"Choi","year":"2024","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128872_bb0040","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/vaccines11081322","article-title":"Seasonal influenza vaccine effectiveness in persons aged 15\u201364 years: a systematic review and meta-analysis","volume":"11","author":"Martins","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128872_bb0045","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128872_bb0050","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2026.128872_bb0055","series-title":"Preliminary estimated flu disease burden 2023\u20132024 flu season","author":"CDC","year":"2025"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128872_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/icb.2009.81","article-title":"The \u03b3-irradiated influenza vaccine and the prospect of producing safe vaccines in general","volume":"88","author":"Alsharifi","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128872_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005336","article-title":"Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections. Unutmaz D, ed","volume":"4","author":"Alsharifi","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128872_bb0070","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.02508-09","article-title":"Cytotoxic T cells are the predominant players providing cross-protective immunity induced by \u03b3-irradiated influenza a viruses","volume":"84","author":"Furuya","year":"2010","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128872_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025765","article-title":"Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7\/MyD88 pathway. Sambhara S, ed","volume":"6","author":"Furuya","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128872_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-3099(06)70443-1","article-title":"Cytotoxic T-cell immunity as a target for influenza vaccines","volume":"6","author":"M\u00fcllbacher","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128872_bb0085","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"Doherty","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2026.128872_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126839","article-title":"Global production capacity of seasonal and pandemic influenza vaccines in 2023","volume":"51","author":"Taaffe","year":"2025","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128872_bb0095","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/14760584.2022.2085565","article-title":"The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing","volume":"21","author":"Trombetta","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128872_bb0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41564-019-0443-4","article-title":"Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity","volume":"4","author":"David","year":"2019","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128872_bb0105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.vaccine.2016.12.044","article-title":"The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine","volume":"35","author":"David","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128872_bb0110","series-title":"Recommended composition of influenza virus vaccines for use in the 2020 southern hemisphere influenza season","year":"2019"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128872_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198182","article-title":"Gamma-irradiated rotavirus: a possible whole virus inactivated vaccine. Ashour HM, ed","volume":"13","author":"Shahrudin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128872_bb0125","unstructured":"CDC. Preliminary Estimated Flu Disease Burden 2024-2025 Flu season. Flu Burden February 26, 2026. Accessed March 29, 2026. https:\/\/archive.cdc.gov\/www_cdc_gov\/flu-burden\/php\/data-vis\/2024-2025.html."},{"issue":"5","key":"10.1016\/j.vaccine.2026.128872_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajic.2023.11.009","article-title":"Influenza vaccination mitigates severe complications in hospitalized patients: a ten-year observational study, Spain, 2009-2019","volume":"52","author":"Mangas-Moro","year":"2024","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128872_bb0135","first-page":"140","article-title":"Effectiveness of influenza vaccine in preventing severe cases of influenza: season 2022\/2023","volume":"42","author":"Platas-Abenza","year":"2024","journal-title":"Enfermedades infecciosas y microbiologia clinica (English ed)"},{"key":"10.1016\/j.vaccine.2026.128872_bb0140","article-title":"Cell-based influenza vaccines: an effective vaccine option for under 60-year-olds","volume":"19","author":"G\u00e4rtner","year":"2024","journal-title":"GMS Hyg Infect Control"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128872_bb0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/ijmr.IJMR_2789_20","article-title":"Inactivation of SARS-CoV-2 by gamma irradiation","volume":"153","author":"Jain","year":"2021","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128872_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1515\/biol-2021-0051","article-title":"Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: potential application for SARS-CoV-2 inactivated vaccine development","volume":"16","author":"Abolaban","year":"2021","journal-title":"Open Life Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600681X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600681X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:42:51Z","timestamp":1789504971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600681X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S0264410X2600681X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128872","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purified gamma-irradiated influenza A vaccine demonstrates high immunogenicity and protection against a drifted H1N1 strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128872"}}